Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.

Yasui H, Inui N, Furuhashi K, Nakamura Y, Uto T, Sato J, Yasuda K, Takehara Y, Suda T, Chida K.

Pulm Pharmacol Ther. 2013 Jun;26(3):336-41. doi: 10.1016/j.pupt.2013.01.005. Epub 2013 Jan 20.

PMID:
23340058
2.

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.

Farne HA, Cates CJ.

Cochrane Database Syst Rev. 2015 Oct 22;(10):CD008989. doi: 10.1002/14651858.CD008989.pub3. Review.

PMID:
26490945
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

Chong J, Karner C, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009157. doi: 10.1002/14651858.CD009157.pub2. Review.

PMID:
22972134
6.

Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison.

Medic G, Lindner L, van der Weijden M, Karabis A.

Adv Ther. 2016 Mar;33(3):379-99. doi: 10.1007/s12325-016-0299-4. Epub 2016 Feb 16. Review.

7.

Budesonide/formoterol pressurized metered-dose inhaler: in chronic obstructive pulmonary disease.

Lyseng-Williamson KA.

Drugs. 2009 Jul 30;69(11):1459-70. doi: 10.2165/00003495-200969110-00005. Review.

PMID:
19634924
8.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
9.

Aclidinium bromide for stable chronic obstructive pulmonary disease.

Ni H, Soe Z, Moe S.

Cochrane Database Syst Rev. 2014 Sep 19;(9):CD010509. doi: 10.1002/14651858.CD010509.pub2. Review.

PMID:
25234126
10.

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.

Cheyne L, Irvin-Sellers MJ, White J.

Cochrane Database Syst Rev. 2015 Sep 22;(9):CD009552. doi: 10.1002/14651858.CD009552.pub3. Review.

PMID:
26391969
11.

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.

Cheyne L, Irvin-Sellers MJ, White J.

Cochrane Database Syst Rev. 2013 Sep 16;(9):CD009552. doi: 10.1002/14651858.CD009552.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(9):CD009552.

PMID:
24043433
12.

Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease.

Centanni S, Di Marco F.

Expert Opin Pharmacother. 2005 Nov;6(14):2525-34. Review. Erratum in: Expert Opin Pharmacother. 2005 Dec;6(15):2779.

PMID:
16259583
13.

Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.

Cazzola M.

Pulm Pharmacol Ther. 2006;19(2):79-89. Epub 2005 Jun 16. Review.

PMID:
15964228
14.

Aclidinium/formoterol fixed-dose combination for the treatment of chronic obstructive pulmonary disease.

Cazzola M, Calzetta L, Matera MG.

Drugs Today (Barc). 2015 Feb;51(2):97-105. doi: 10.1358/dot.2015.51.2.2273382. Review.

PMID:
25756065
15.

The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease.

Karia S, Mahadeva R, Balan A, Babar J.

Clin Radiol. 2015 Jul;70(7):752-9. doi: 10.1016/j.crad.2015.02.015. Epub 2015 Apr 8. Review.

PMID:
25861874

Supplemental Content

Support Center